1. Long non-coding RNA SNHG5 suppresses the development of acute respiratory distress syndrome by targeting miR-205/COMMD1 axis
   Jiao Wang et al, 2021, Molecular and Cellular Biochemistry CrossRef
2. Application of Antioxidants in Curing Respiratory and Pulmonary Disorders
   Ittishree Bhardwaj et al, 2024, Current Nutrition & Food Science CrossRef
3. Chronic Inflammation and Chronic Diseases: Potential Healing with Glutathione‐Inspired Fragments
   Wafaa Bouazzaoui et al, 2022, ChemistrySelect CrossRef
4. Do Diet and Dietary Supplements Mitigate Clinical Outcomes in COVID-19?
   Bhavdeep Singh et al, 2022, Nutrients CrossRef
5. N-acetilcisteína en el síndrome de dificultad respiratoria aguda: análisis de costo-efectividad para Colombia
   Martín Romero-Prada et al, 2023, Revista Investigación en Salud Universidad de Boyacá CrossRef
6. Long non-coding RNA MALAT1 exacerbates acute respiratory distress syndrome by upregulating ICAM-1 expression via microRNA-150-5p downregulation
   Meng-Ying Yao et al, 2020, Aging CrossRef
7. Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention
   Aikaterini Nasi et al, 2020, Toxicology Reports CrossRef
8. Treatment for acute respiratory distress syndrome in adults: a narrative review of phase 2 and 3 trials
   Denise Battaglini et al, 2022, Expert Opinion on Emerging Drugs CrossRef
9. N-acetylcysteine for adults with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials
   Xin Lu et al, 2019, Hong Kong Journal of Emergency Medicine CrossRef
10. An update on the pharmacological management of acute respiratory distress syndrome
    Denise Battaglini et al, 2024, Expert Opinion on Pharmacotherapy CrossRef
11. Neutrophils in the initiation and resolution of acute pulmonary inflammation: understanding biological function and therapeutic potential
    Philippe MD Potey et al, 2019, The Journal of Pathology CrossRef
12. Challenges in ARDS Definition, Management, and Identification of Effective Personalized Therapies
    Denise Battaglini et al, 2023, Journal of Clinical Medicine CrossRef
13. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on “Two-Path Unifying Theory” of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy
    Jae Chang, 2021, Vascular Health and Risk Management CrossRef
14. COVID-19: oxidative stress and the relevance of antioxidant therapy
    Marina A. Darenskaya et al, 2020, Annals of the Russian academy of medical sciences CrossRef
15. The Association of Respiratory Viruses with Oxidative Stress and Antioxidants. Implications for the COVID-19 Pandemic
    Marina Darenskaya et al, 2021, Current Pharmaceutical Design CrossRef
16. Impact of antioxidants on PM2.5 oxidative potential, radical level, and cytotoxicity
    Yixiang Wang et al, 2024, Science of The Total Environment CrossRef
17. Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
    Chih-Chao Chiang et al, 2020, Frontiers in Pharmacology CrossRef
18. N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study
    Stelios F. Assimakopoulos et al, 2021, Infectious Diseases CrossRef
19. Industry-funded versus non-profit-funded critical care research: a meta-epidemiological overview
    Perrine Janiaud et al, 2018, Intensive Care Medicine CrossRef
20. The role of neutrophil extracellular traps (NETs) in the immunopathogenesis of severe COVID-19: potential immunotherapeutic strategies regulating NET formation and activity
    Irina V. Nesterova et al, 2023, Russian Journal of Infection and Immunity CrossRef
21. The interplay between mitophagy and mitochondrial ROS in acute lung injury
    Yizhi Zhong et al, 2024, Mitochondrion CrossRef
22. Preventing the development of severe COVID-19 by modifying immunothrombosis
    Gerwyn Morris et al, 2021, Life Sciences CrossRef
23. N-acetylcysteine and coronavirus disease 2019: May it work as a beneficial preventive and adjuvant therapy? A comprehensive review study
    Azadeh Goodarzi et al, 2020, Journal of Research in Medical Sciences CrossRef
24. Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial
    Aaron M. Gusdon et al, 2022, Science Translational Medicine CrossRef
25. Pharmacological therapies for acute respiratory distress syndrome
    Robert Ivaşcu et al, 2019, Central European Journal of Clinical Research CrossRef
26. Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
    Ozlem Altay et al, 2021, Advanced Science CrossRef
27. Association of Low Molecular Weight Plasma Aminothiols with the Severity of Coronavirus Disease 2019
    Evgeny Vladimirovich Kryukov et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
28. Disease‐modifying treatment of chemical threat agent–induced acute lung injury
    Jared Radbel et al, 2020, Annals of the New York Academy of Sciences CrossRef
29. The Role of Antioxidant Agent (N-Acetylcysteine) in Oleic Acid-Induced Acute Lung Injury in a Rat Model
    Sudhashekhar Kumar et al, 2022, Cureus CrossRef
30. ARDS: challenges in patient care and frontiers in research
    Lieuwe D. Bos et al, 2018, European Respiratory Review CrossRef
31. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome
    Abbas Taher et al, 2021, Pharmacological Reports CrossRef
32. Pharmacological agents for adults with acute respiratory distress syndrome
    Sharon R Lewis et al, 2019, Cochrane Database of Systematic Reviews CrossRef
33. Friend or Foe? The Roles of Antioxidants in Acute Lung Injury
    Yang Liu et al, 2021, Antioxidants CrossRef
34. The effects of N‐acetylcysteine on recovery biomarkers: A systematic review and meta‐analysis of controlled trials
    Marzieh Nejati et al, 2022, Journal of Food Biochemistry CrossRef
35. Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology
    George J Kontoghiorghes et al, 2019, Expert Opinion on Investigational Drugs CrossRef
36. The many faces of the anti-COVID immune response
    Santosha A. Vardhana et al, 2020, Journal of Experimental Medicine CrossRef
37. [Retracted] Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome
    Lin Liu et al, 2022, Contrast Media & Molecular Imaging CrossRef
38. SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities
    Mohammad Shah Alam et al, 2022, Cytokine & Growth Factor Reviews CrossRef
39. Effect of Nebulized Heparin on Weaning off Intubated Patients with Acute Respiratory Distress Syndrome (ARDS) Admitted to Intensive Care Unit (ICU): A Randomized Clinical Trial
    Alireza Olapour et al, 2021, Anesthesiology and Pain Medicine CrossRef
40. Resveratrol decreases CD45+CD206− subtype macrophages in LPS‐induced murine acute lung injury by SOCS3 signalling pathway
    Lu Hu et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
41. Effects of acetylcysteine on micro-inflammation and pulmonary ventilation in chronic obstructive pulmonary disease exacerbation
    Li-Yuan Huang et al, 2024, World Journal of Clinical Cases CrossRef
42. OBSERVATIONAL STUDY ON CLINICAL FEATURES, TREATMENT AND OUTCOME OF COVID 19 IN A TERTIARY CARE CENTRE IN INDIA - A RETROSPECTIVE CASE SERIES
    Raja Bhattacharya et al, 2020, INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH CrossRef
43. Efficacy of 3% hypertonic saline in bronchiolitis: A meta‑analysis
    Zhi‑Yong Wang et al, 2019, Experimental and Therapeutic Medicine CrossRef
44. Protective action of N-acetyl-L-cysteine associated with a polyvalent antivenom on the envenomation induced by Lachesis muta muta (South American bushmaster) in rats
    Aline G. Leão-Torres et al, 2021, Toxicon CrossRef
45. N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2
    Francis L. Poe et al, 2020, Medical Hypotheses CrossRef
46. Acute Respiratory Distress Syndrome as an Organ Phenotype of Vascular Microthrombotic Disease: Based on Hemostatic Theory and Endothelial Molecular Pathogenesis
    Jae C. Chang, 2019, Clinical and Applied Thrombosis/Hemostasis CrossRef
47. The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review
    Philip T James et al, 2021, The Journal of Nutrition CrossRef
48. Actualización de la Declaración de consenso en medicina critica para la atención multidisciplinaria del paciente con sospecha o confirmación diagnóstica de COVID-19
    Jose Luis Accini Mendoza et al, 2020, Acta Colombiana de Cuidado Intensivo CrossRef
49. Lung targeted liposomes for treating ARDS
    Sivan Arber Raviv et al, 2022, Journal of Controlled Release CrossRef
50. Anti-inflammatory therapies for acute respiratory distress syndrome
    Denise Battaglini et al, 2023, Expert Opinion on Investigational Drugs CrossRef
51. Exploring the role of antioxidants in sepsis-associated oxidative stress: a comprehensive review
    Dipak Kumar Sahoo et al, 2024, Frontiers in Cellular and Infection Microbiology CrossRef